Omega Healthcare Investors Files 8-K

Ticker: OHI · Form: 8-K · Filed: 2025-05-12T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

Related Tickers: OHI

TL;DR

OHI filed an 8-K on 5/12/25, check for updates.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on May 12, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or operational details in the provided text, but indicates a report date of May 12, 2025.

Why It Matters

This filing signals an update or disclosure from Omega Healthcare Investors, Inc. to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial or operational risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

What is the exact name of the registrant?

The exact name of the registrant is OMEGA HEALTHCARE INVESTORS, INC.

On what date was this report filed or effective?

The report was filed as of May 12, 2025, and the date of the earliest event reported is May 12, 2025.

What is the company's state of incorporation and IRS Employer Identification No.?

The company is incorporated in Maryland and its IRS Employer Identification No. is 38-3041398.

What is the company's principal executive office address and phone number?

The principal executive office is located at 303 International Circle Suite 200 Hunt Valley, Maryland 21030, and the telephone number is (410) 427-1700.

From the Filing

0001104659-25-047318.txt : 20250512 0001104659-25-047318.hdr.sgml : 20250512 20250512162023 ACCESSION NUMBER: 0001104659-25-047318 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250512 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250512 DATE AS OF CHANGE: 20250512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 25935165 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2514849d1_8k.htm FORM 8-K false 0000888491 0000888491 2025-05-12 2025-05-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): May 12, 2025   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:       Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨           Item 7.01 Regulation FD Disclosure.   On May 12, 2025, Omega Healthcare Investors, Inc. (“Omega” or the “Company”) issued a press release announcing that it had posted to its website, www.omegehealthcare.com, under the Investor Relations section and under the News & Events section, an updated investor presentation which includes a revised Operator Updates slide on page 9 of the presentation. The updated investor presentation is titled “May 2025 Investor Presentation.” The presentation will remain on the Company’s website for a period of at least thirty days. Omega’s press release is attached as Exhibit 99.1 to this Curren

View on Read The Filing